The -omics era: proteomics and lipidomics in vascular research.
A main limitation of the current approaches to atherosclerosis research is the focus on the investigation of individual factors, which are presumed to be involved in the pathophysiology and whose biological functions are, at least in part, understood. These molecules are investigated extensively while others are not studied at all. In comparison to our detailed knowledge about the role of inflammation in atherosclerosis, little is known about extracellular matrix remodelling and the retention of individual lipid species rather than lipid classes in early and advanced atherosclerotic lesions. The recent development of mass spectrometry-based methods and advanced analytical tools are transforming our ability to profile extracellular proteins and lipid species in animal models and clinical specimen with the goal of illuminating pathological processes and discovering new biomarkers.
King's British Heart Foundation Centre, King's College London, UK.
Athanasios
A
Didangelos
Christin
C
Stegemann
Manuel
M
Mayr
D050197:Atherosclerosis / Q000378:metabolism*; D035843:Biomedical Research / Q000379:methods*; D001808:Blood Vessels / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D013058:Mass Spectrometry; D055432:Metabolomics; D040901:Proteomics